OCUGEN, INC. (OCGN) Reports the reporting period Financial Results
OCUGEN, INC. (OCGN) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 1533
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: $32
answer session following the prepared remarks. Attendees are invited to participate on the call or webcast using the following details: Dial
in Numbers: (800) 715
9871 for U.S. callers and (646) 307
planned for the third quarter of 2026
Targeting Three BLA Filings in the Next Three Years OCU400 ·Completed Phase 3 liMeliGhT enrollment (N=140 subjects). Topline Phase 3 data expected in the first quarter of 2027
📋 OCUGEN, INC. (OCGN) - Financial Results
Filing Date: 2026-05-05
Accepted: 2026-05-05 11:37:19
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: